Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
基本信息
- 批准号:10714634
- 负责人:
- 金额:$ 34.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:Abnormal CellAddressAgingBiochemistryCaenorhabditis elegansCancer EtiologyCell CycleCell Cycle RegulationCell Cycle StageCell Differentiation processCell ProliferationCellsComplexCuesCyclin BDefectDevelopmentDiseaseEmbryonic DevelopmentEquilibriumEventFailureGenerationsGenomicsGoalsIn VitroMalignant NeoplasmsMitosisMitoticMolecularNutrientNutritionalOrganismPathway interactionsProliferatingRegulationResearchSignal TransductionTissuesWorkcell fate specificationin vivoinsightpreventprogramsresponse
项目摘要
PROJECT SUMMARY
The development of an organism requires a delicate balance of cell proliferation with cell cycle exit events that
necessitates the regulation of the cell cycle machinery to interface with the developmental program. Among
critical cell cycle exit events during development are cell differentiation and cell cycle pause, also known as
quiescence. The decision to proliferate or exit the cell cycle is influenced by a multitude of factors, including
developmental, environmental and nutritional cues. Failures in these decisions are the cause of cancer, as well
as developmental abnormalities and aging-related disorders. My overarching goal is to address how the core
cell cycle machinery integrates diverse inputs to execute the decision to enter and exit the quiescent state and
to couple the cell cycle to cell fate determination during development. My prior work employing C. elegans
provided fundamental new insights into the control of cell cycle state transitions in an in vivo context. Using the
developing germline, a tissue of utmost importance for the accurate propagation of the genomic information
across generations and where cell cycle regulation is tied to nutrient signaling, I uncovered a conserved
molecular mechanism that allows for the accumulation of cyclin B to drive entry into mitosis. I also determined
how the cell cycle machinery is specialized in different developmental contexts to promote cell proliferation, with
particular emphasis on the Cdk1-Cyclin B complex that coordinates mitotic entry and exit events. In this proposal,
my group will capitalize on our expertise in cell cycle regulation mechanisms, in vitro biochemistry and
developmental analyses to delineate the molecular mechanism by which germline precursors enter into and exit
from a non-cannonical form of quiescence at the G2 stage of the cell cycle in response to nutrient signaling, to
address how these signals interface with the pathways that regulate entry into mitosis, and to determine how the
cell cycle machinery intersects with cell fate specification to promote cell differentiation during embryonic
development. This work will drive new understanding of how cell cycle decision points are regulated during
development, which could help prevent and/or treat disorders originating from cell proliferation defects.
项目摘要
生物体的发育需要细胞增殖与细胞周期退出事件的微妙平衡,
需要调节细胞周期机制,以与发育程序相结合。之间
在发育过程中,关键的细胞周期退出事件是细胞分化和细胞周期暂停,也称为细胞周期暂停。
安静增殖或退出细胞周期的决定受到多种因素的影响,包括
发育、环境和营养线索。这些决定的失败也是癌症的原因
发育异常和衰老相关疾病。我的首要目标是解决
细胞周期机制整合不同的输入以执行进入和退出静止状态的决定,
在发育过程中将细胞周期与细胞命运决定相结合。我以前的工作是用C。elegans
提供了基本的新的见解控制细胞周期状态转换在体内的情况下。使用
发育生殖系,这是一种对基因组信息的准确传播至关重要的组织
在细胞周期调控与营养信号联系的情况下,我发现了一个保守的
允许细胞周期蛋白B积累以驱动进入有丝分裂的分子机制。我还决定
细胞周期机制如何在不同的发育环境中专门化以促进细胞增殖,
特别强调Cdk 1-细胞周期蛋白B复合物,其协调有丝分裂进入和退出事件。在这一提议中,
我的团队将利用我们在细胞周期调节机制、体外生物化学和
发育分析,以描绘生殖系前体进入和退出的分子机制
从响应营养信号的细胞周期G2期的非典型形式的静止,到
解决这些信号如何与调节进入有丝分裂的途径相互作用,并确定这些信号如何与细胞分裂信号相互作用。
细胞周期机制与细胞命运特化交叉以促进胚胎期细胞分化
发展这项工作将推动对细胞周期决策点如何在细胞周期中调节的新理解。
本发明提供了一种用于促进细胞发育的药物组合物,其可以帮助预防和/或治疗源自细胞增殖缺陷的病症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pablo Andres Lara-Gonzalez其他文献
Pablo Andres Lara-Gonzalez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.11万 - 项目类别:
Research Grant